Hims & Hers Health HIMS
NYSE HIMS
$27.44 -0.46 (-1.65%)
As of: Sep 10, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026)

Hims & Hers Health's (HIMS) quarterly Amortization of Deferred Charges came in at $1.6 million in Q2 2026, up 297.53% year-over-year from $402484.5 in Q2 2025, and down 5.94% quarter-over-quarter from $1.7 million in Q1 2026.

Analysis

Hims & Hers Health (HIMS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $1.6 million for Q2 2026.

  • In Q2 2026, Amortization of Deferred Charges rose 297.53% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $6.6 million (up 919.75% YoY), while the FY2025 annual figure was $4.5 million, changed N/A from the prior year.
  • Amortization of Deferred Charges came in at $1.6 million for Q2 2026 at Hims & Hers Health, down from $1.7 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.7 million in Q4 2025 to a low of -$810000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 6.99 Bn 6.60 Bn 183.95 Mn
2 Hims & Hers Health 6.38 Bn 5.54 Bn 480.80 Mn
3 Ethos Technologies 2.47 Bn 2.30 Bn 185.54 Mn
4 Omada Health 1.28 Bn 1.06 Bn 63.79 Mn
5 Teladoc Health 1.11 Bn 330.82 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 208.18 Mn 208.01 Mn -
8 LifeMD 145.04 Mn 145.04 Mn -
9 eHealth 29.43 Mn -71.61 Mn -
10 Mangoceuticals 6.82 Mn 6.58 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.60 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 1.74 Mn
Sep 30, 2025 1.60 Mn
Jun 30, 2025 -810,000.00
Mar 31, 2021 144,000.00
Dec 31, 2020 71,000.00
Sep 30, 2020 84,000.00
Jun 30, 2020 83,000.00
Mar 31, 2020 84,000.00